Positron emission tomography in neoplasms of the digestive system

Positron emission tomography in neoplasms of the digestive system

PET/CT has proven to be extremely useful in studying neoplasms of the colon and esophagus. It has been less promising for lesions of the stomach, pancreas and hepatobiliary tract. Colorectal cancer is the third most common non-cutaneous cancer representing 13% of all malignancies. The use of col...

Full description

Bibliographic Details
Main Authors:	Mihailović Jasna, Freeman Leonard M.
Format:	Article
Language:	English
Published:	Institute of Oncology, Sremska Kamenica, Serbia 2012-01-01
Series:	Archive of Oncology
Subjects:	Positron-Emission Tomography and Computed Tomography Gastrointestinal Neoplasms Colorectal Neoplasms Esophageal Neoplasms Stomach Neoplasms Pancreatic Neoplasms Carcinoma Hepatocellular
Online Access:	http://www.doiserbia.nb.rs/img/doi/0354-7310/2012/0354-73101204086M.pdf

Similar Items

Asymptomatic Thymic Carcinoma With Solitary Hepatic Metastasis Detected by Fluorodeoxyglucose Positron Emission Tomography
by: Lien-Yen Wang, et al.
Published: (2009-08-01)

False Positive 18F-FDG Positron Emission Tomography Findings in Schwannoma—A Caution for Reporting Physicians
by: Paul Boré, et al.
Published: (2018-10-01)

The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: Simone Serafini, et al.
Published: (2020-03-01)

Clinical Etiology of Hypermetabolic Pelvic Lesions in Postoperative Positron Emission Tomography/Computed Tomography for Patients With Rectal and Sigmoid Cancer
by: Yun Hee Kang, et al.
Published: (2018-04-01)

Does Diabetes Mellitus Influence Standardized Uptake Values of Fluorodeoxyglucose Positron Emission Tomography in Colorectal Cancer?
by: Da Yeon Oh, et al.
Published: (2014-04-01)

Diagnostic and prognostic value of preoperative ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography
by: Joo Young Lee, et al.
Published: (2017-04-01)

Effects of contrast enhanced positron emission tomography/computed tomography in cancer imaging
by: Mahmud, Mohd Hafizi
Published: (2015)

Use of F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Rare Head and Neck Cancers
by: Jong-Lyel Roh, et al.
Published: (2008-06-01)

Assessment of Diet Quality and Adherence to Dietary Guidelines in Gastrointestinal Cancer Survivors: A Cross-Sectional Study
by: Sara Moazzen, et al.
Published: (2020-07-01)

Pulmonary actinomycosis mimicking lung cancer on positron emission tomography
by: Hayoung Choi, et al.
Published: (2017-01-01)

Evaluation of a dog with inflammatory mammary carcinoma using 18F‐2‐deoxy‐2‐fluoro‐d‐glucose positron emission tomography/computed tomography
by: Yoonhoi Koo, et al.
Published: (2022-07-01)

Diet Quality and Upper Gastrointestinal Cancers Risk: A Meta-Analysis and Critical Assessment of Evidence Quality
by: Sara Moazzen, et al.
Published: (2020-06-01)

F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review
by: Schröer-Günther Milly A, et al.
Published: (2012-12-01)

Impact of OCT4 and Its Related Signaling Pathways on Gastrointestinal Cancers: Focusing on Targeted Therapy
by: Hamid Cheshomi, et al.
Published: (2020-06-01)

Bone: From planar imaging to SPECT & PET/CT
by: Mihailović Jasna, et al.
Published: (2012-01-01)

Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer
by: Nuno Dias, et al.
Published: (2022-12-01)

Development and Validation of a Radiomics Nomogram for Liver Metastases Originating from Gastric and Colorectal Cancer
by: Yuying Li, et al.
Published: (2023-09-01)

THE ESOPHAGEAL, GASTRIC, AND COLORECTAL TUMORS AND THE ESOPHAGOGASTRODUODENOSCOPIES AND COLONOSCOPIES BY THE BRAZILIAN UNIFIED HEALTH SYSTEM: WHAT IS THE IMPORTANCE?
by: Marilisa Ferruda Andreoli RISSO, et al.
Published: (2022-06-01)

PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms
by: Lucia Moletta, et al.
Published: (2018-05-01)

Should the Endoscopic Restrictions during COVID-19 Pandemic Remain Unchanged?
by: Emilio Bresky, et al.
Published: (2021-08-01)

PET/CT in thyroid carcinoma
by: Mihailović Jasna
Published: (2012-01-01)

Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis
by: Hannah C. Puhr, et al.
Published: (2021-10-01)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with <sup>18</sup>F-FDG PET Radiomics Based Machine Learning Classification
by: Roelof J. Beukinga, et al.
Published: (2022-04-01)

The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
by: Mihailović Jasna, et al.
Published: (2017-01-01)

Predictive Value of <sup>18</sup>F-Fluorodeoxyglucose Positron-Emission Tomography Metabolic and Volumetric Parameters for Systemic Metastasis in Tonsillar Cancer
by: Jooin Bang, et al.
Published: (2022-12-01)

Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
by: Xianwen Hu, et al.
Published: (2022-11-01)

Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
by: Ziya Akbulut, et al.
Published: (2011-06-01)

Preoperative Positron-Emision Tomography/Computed Tomography Findings in Endometrial Cancer: A Study of 30 Cases
by: Duygu Altın, et al.
Published: (2017-08-01)

Infrequent association between colon and prostate tumor, a clinico-radiological case
by: Alexander Sosa-Frias
Published: (2021-05-01)

Interrelationship between Liver Hemodynamics and Tumor Metabolism in Liver Metastases: Diagnostic Value of Doppler Perfusion Index Revisited
by: Banu Alicioglu, et al.
Published: (2013-01-01)

Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors
by: Masaya Iwamuro, et al.
Published: (2020-05-01)

A Case of Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm Composed With Adenoma and Neuroendocrine Tumor
by: Kwon-Eui Hong, et al.
Published: (2023-12-01)

Endoscopic ultrasound in the pre-therapeutic staging of gastroesophageal adenocarcinoma: the diagnostic value in defining patients eligible for a neoadjuvant chemotherapy regimen
by: Wilko Staiger, et al.
Published: (2010-03-01)

Contribution of 18-fluorodeoxyglucose positron emission tomography (FDG PET) imaging in the detection of underlying carcinoma in a woman with nonspecific mastitis
by: Hancerliogulları Oguz, et al.
Published: (2018-01-01)

Preoperative Risk Factors for Pathologic N2 Metastasis in Positron Emission Tomography-Computed Tomography–Diagnosed N0–1 Non-Small Cell Lung Cancer
by: Tae-hong Yoon, et al.
Published: (2019-08-01)

The Frequency of Focal Thyroid Incidental Findings and Risk of Malignancy Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography in an Iodine Deficient Population
by: Nina Gedberg, et al.
Published: (2018-07-01)

A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy
by: Lu Han, et al.
Published: (2021-07-01)

Micronuclei in peripheral blood lymphocytes of patients with of the gastrointestinal cancer
by: Bahareh Abbasi, et al.
Published: (2017-05-01)

Diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms by nuclear medicine: Update and future perspective
by: Xing Ma, et al.
Published: (2022-11-01)

Prognostic Value of Bone Marrow Uptake Using 18F-FDG PET/CT Scans in Solid Neoplasms
by: Francisco Tustumi, et al.
Published: (2022-10-01)